Genen­tech vet Myr­tle Pot­ter takes a lead­ing role in Vivek Ra­maswamy's fast-mov­ing Vant ops

The tal­ent mag­net that is Vivek Ra­maswamy’s Roivant Sci­ences has at­tract­ed a biotech vet­er­an to over­see op­er­a­tions of the ever-grow­ing Vant king­dom.

Myr­tle Pot­ter, a for­mer pres­i­dent and COO of Genen­tech, has been named Vant op­er­at­ing chair. The role grants her an au­to­mat­ic board mem­ber­ship at each of Roivant’s 12 biotech sub­sidiaries, where she is ex­pect­ed to as­sist the (of­ten high-pro­file) CEOs and “en­sure op­er­a­tional ex­cel­lence.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER